Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about RHHBY

Recent news which mentions RHHBY

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
AI: An Endless Opportunity or Existential Threat?
Tickers AAPL GOOGL ICAD IRBT
Tags Market Analysis RHHBY IRBT
From InvestorPlace
Why Shares of Zentalis Pharmaceuticals Dropped This Week
Tickers RHHBY ZNTL
Tags RHHBY ZNTL Market News
From Motley Fool
Why Shares of Rain Oncology Are Plummeting Today
Tickers RAIN RHHBY
Tags Market News RHHBY RAIN
From Motley Fool
Apple Thwarts $2B In Fraud Transactions, UBS Takes $17B Hit From 'Hasty Credit Suisse Takeover,' Verizon Streamlines Unlimited Data Plans: Today's Top Stories
Tickers ABBV AZN BCS CS
Tags Market News TGT Top Stories
From Benzinga
Roche's Investigational Drug For Relapsing Multiple Sclerosis Reduces Brain Lesions, Data Shows
Tickers MKGAF RHHBF RHHBY RHHVF
Tags Health Care Market News Briefs
From Benzinga
AI Meets Biotech: Transforming the Drug Development Process
Tickers AZN BAYRY RHHBY SNY
Tags OTCMKTS:BAYRY,OTCMKTS:RHHBY,Nasdaq:SNY,Nasdaq:AZN AZN RHHBY
From InvestorPlace
3 Stocks That Are Reshaping the Future
Tickers MSFT RHHBY ZBH
Tags ZBH MSFT Stocks to Buy
From InvestorPlace
3 Personalized Medicine Stocks to Buy for Long-Time Returns
Tickers ADPT EXAS GSK ME
Tags EXAS ME NASDAQ:EXAS,NYSE:GSK,NASDAQ:ADPT,OCTMKTS:RHHBY,NASDAQ:ME
From InvestorPlace
EXCLUSIVE: SAB Biotherapeutics' Influenza Immunotherapy Shows Safety, Efficacy In Early-Stage Trials
Tickers RHHBY SABS
Tags Exclusives Penny Stocks Market/Moving Exclusives
From Benzinga
Tempest Therapeutics' TPST-1120 Shines In Early Phase 1b/2 Study: Analysts Get Bullish
Tickers RHHBY TPST
Tags Expert Ideas Reiteration Market News
From Benzinga
Roche's Q1 Highlights: Increased Uptake Of Eye Disease Drug Cushions Sales Decline
Tickers RHHBF RHHBY RHHVF
Tags RHHVF Large Cap Market News
From Benzinga
EXCLUSIVE: SAB Biotherapeutics Releases Topline Data From Discontinued COVID Antibody Trial
Tickers REGN RHHBY SABS
Tags Market News Market/Moving Exclusives RHHBY
From Benzinga
3 Top Biotech Stocks Defying the Bear Market
Tickers BGNE BIIB LLY NVS
Tags TGTX BGNE LLY
From Motley Fool
This Company's Non-Invasive Tech Looks To Be Unique In the Market And Can Help People Take Ownership Over Monitoring Their Health
Tickers ABT DXCM RHHBY TECH
Tags Partner Content Benzinga General
From Benzinga
FDA Approves Roche's Polivy Combo Therapy For Untreated Patients With Diffuse Large B-Cell Lymphoma
Tickers RHHBF RHHBY RHHVF
Tags Benzinga General Biotech
From Benzinga
EXCLUSIVE: FDA Grants Expedited Review Status To SAB Biotherapeutics' Influenza Antibody
Tickers RHHBF RHHBY RHHVF SABS
Tags Market News Health Care RHHVF
From Benzinga
Why Shares of Adaptimmune Therapeutics Jumped Tuesday
Tickers ADAP GSK RHHBY
Tags Recent Press Releases RHHBY ADAP
From Motley Fool
Bolt Biotherapeutics Says Phase 1 Data Supports Advancing Into Phase 2 Studies
Tickers BMY BOLT RHHBY
Tags Health Care Market News Penny Stocks
From Benzinga
Roche's Slow Growth Shouldn't Drive Investors Away
Tickers RHHBY
Tags Market News RHHBY Recent Press Releases
From Motley Fool
Roche Joins Hand With Lilly To Improve Early Diagnosis Of Alzheimer's Disease
Tickers LLY RHHBY
Tags General Benzinga News
From Benzinga
New Four Year Data For Roche's Evrysdi Reinforces Long-Term Efficacy, Safety Profile In Muscular Atrophy Patients
Tickers RHHBF RHHBY RHHVF
Tags Large Cap RHHBY RHHBF
From Benzinga
Is Roche a Buy Now?
Tickers RHHBY
Tags Market News RHHBY Recent Press Releases
From Motley Fool
Sarepta Plunges As FDA Takes Surprise Turn; AdComm Meeting Set For Duchenne Gene Therapy
Tickers RHHBY SRPT
Tags Briefs Market News Movers
From Benzinga
FDA Casts Doubts Over Roche's Polivy Label Expansion For Untreated Lymphoma Setting
Tickers RHHBF RHHBY RHHVF
Tags Briefs RHHVF Health Care
From Benzinga
The Top 7 Growth Stocks in Biotech
Tickers APVO BEAM CMRX DVAX
Tags VIR DVAX Stocks to Buy
From InvestorPlace
Roche, Exelixis Report Second Flop Out Of Three Trials Evaluating Cabozantinib/Atezolizumab Combo
Tickers EXEL RHHBF RHHBY RHHVF
Tags EXEL Market News Health Care
From Benzinga
Why Sarepta Therapeutics' Shares Rose 23.4% This Week
Tickers RHHBY SRPT
Tags Recent Press Releases RHHBY Market News
From Motley Fool
3 Best Growth Stocks to Buy In March
Tickers HIMS IWF MELI RHHBY
Tags IWF MELI RHHBY
From Motley Fool
Blueprint Medicines Highlights Detailed Data From Lead Product In Blood Cancer Patients
Tickers BPMC RHHBY
Tags Market News Health Care RHHBY
From Benzinga
Roche Decides To Terminate Cancer Treatment Pact With Blueprint Medicines
Tickers BPMC RHHBF RHHBY RHHVF
Tags News RHHBF RHHBY
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.